Interlaboratory concordance of p16/Ki‐67 dual‐staining interpretation in HPV‐positive women in a screening population

Authors:
Publisher website
Google Scholar
Abstract
Background: p16/Ki‐67 dual staining is a candidate biomarker for triaging human papillomavirus (HPV)–positive women. Reproducibility is needed for adopting a test for screening. This study assessed interlaboratory reproducibility in HPV‐positive women.Methods: All women positive for HPV from the Italian New Technologies for Cervical Cancer 2 study, were included in this study. ThinPrep slides were immunostained for p16/Ki‐67 in 4 laboratories and were interpreted in 7 laboratories. Each slide had 3 reports from different laboratories. Slides were classified as valuable or inadequate, and valuable slides were classified as positive (at least 1 double‐stained cell) or negative. Interlaboratory reproducibility was evaluated with κ values.Results: Overall, we obtained 9300 reports for 3100 cases; 905 reports (9.7%) were inadequate. The overall adequacy concordance was poor (κ = 0.224; 95% confidence interval [CI], 0.183‐0.263). The overall positivity concordance was moderate (κ = 0.583; 95% CI, 0.556‐0.610). Of the 176 cervical intraepithelial neoplasia 2+ (CIN‐2+) lesions found in HPV DNA–positive women, 158 had a valid result: 107 were positive in all 3 reports (sensitivity for CIN‐2+, 67.7%; 95% CI, 59.8%‐74.9%), 23 were positive in 2 reports (sensitivity of the majority report, 82.3%; 95% CI, 75.4%‐87.9%), and 15 were positive in 1 report (sensitivity of at least 1 positive result, 91.8%; 95% CI, 86.3%‐95.5%). Thirteen CIN‐2+ cases were negative in all 3 reports. The overall positivity concordance in CIN‐2+ samples was κ = 0.487 (95% CI, 0.429‐0.534), whereas in the non–CIN‐2+ samples, it was κ = 0.558 (95% CI, 0.528‐0.588).Conclusions: The p16/Ki‐67 assay showed poor reproducibility for adequacy and good reproducibility for positivity comparable to that of cervical cytology. Nevertheless, the low reproducibility does not affect the sensitivity for CIN‐2+.
Funding Information
  • Ministry of Health (RF‐2009‐1536040)

This publication has 22 references indexed in Scilit: